Literature DB >> 8425423

Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis.

J A Leighton1, M A Valdovinos, J H Pemberton, D M Rath, M Camilleri.   

Abstract

Our aim was to characterize the clinical spectrum of anorectal dysfunction among eight patients with progressive systemic sclerosis (PSS) who presented with altered bowel movements with or without fecal incontinence. The anorectum was assessed by physical examination, proctosigmoidoscopy, and anorectal manometry. There was concomitant involvement of the other regions of the digestive tract in all patients as determined by barium studies, endoscopy, or manometry: eight esophageal, three gastric, four small bowel, and two colonic. Seven patients had fecal incontinence, and four also had second-degree complete rectal prolapse. Abnormal anorectal function, particularly abnormal anal sphincter resting pressures, were detected in all patients; anal sphincter pressures were lower in those with rectal prolapse. Rectal capacity and wall compliance were impaired in seven of seven patients. Successful surgical correction of prolapse in three patients resulted in restoration of incontinence for six months and seven years in two of the three patients. We conclude that rectal dysfunction and weakness of the anal sphincters are important factors contributing, respectively, to altered bowel movements and fecal incontinence in patients with gastrointestinal involvement by PSS. Rectal prolapse worsens anal sphincter dysfunction and should be sought routinely as it is a treatable factor aggravating fecal incontinence in patients with PSS.

Entities:  

Mesh:

Year:  1993        PMID: 8425423     DOI: 10.1007/bf02051176

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

1.  Investigation of anal function in patients with systemic sclerosis.

Authors:  A L Herrick; J D Barlow; A Bowden; N Williams; A R Hobson; M Irving; M I Jayson
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

Review 2.  Combined urinary and faecal incontinence.

Authors:  Dharmesh S Kapoor; Ranee Thakar; Abdul H Sultan
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-02-24

3.  Uterine prolapse in a young nulligravida with scleroderma and premature ovarian failure.

Authors:  Birol Vural; Eray Caliskan; Emek Doger; Cengiz Ercin
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-01-15

4.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

Review 5.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

6.  Sacral nerve stimulation for faecal incontinence due to systemic sclerosis.

Authors:  N J Kenefick; C J Vaizey; R J Nicholls; R Cohen; M A Kamm
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

7.  Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.

Authors:  Franco Cozzi; Giancarlo Parisi; Luca Ciprian; Arianna Bullo; Silvia Cardarelli; Michela Rizzo; Paolo Sfriso; Leonardo Punzi
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

8.  Evaluation of anal incontinence: minimal approach, maximal effectiveness.

Authors:  Harry T Papaconstantinou
Journal:  Clin Colon Rectal Surg       Date:  2005-02

9.  Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence.

Authors:  A F Engel; M A Kamm; I C Talbot
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

10.  Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence.

Authors:  Gregory J Heyt; Mina K Oh; Nazanin Alemzadeh; Susie Rivera; Sergio A Jimenez; Satish Rattan; Sidney Cohen; Anthony J Dimarino
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.